Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sequenom Inc (NASDAQ:SQNM)

Delayed Data
As of Jul 31
 +0.02 / +0.71%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

SEQUENOM, Inc. operates as a life sciences company providing innovative genomic and genetic analysis solutions for the clinical research and molecular diagnostic markets. The company operates its business under two segments: Sequenom Laboratories and Sequenom Bioscience. The Sequenom Laboratories segment runs through its subsidiary, Sequenom Center for Molecular Medicine, LLC, which performs molecular diagnostic testing services utilizing its laboratory-developed tests which are currently focused on noninvasive prenatal and women's health related diagnostics and ophthalmology-related diagnostics and plans to develop or acquire additional diagnostic tests in those and other fields, including autoimmunity, neurology and oncology. The Sequenom Bioscience segment provides research use technologies and tools that translate the results of genomic science into solutions for biomedical research, translational research, oncology, agricultural genomics, clinical diagnostics, molecular medicine applications, and other areas of research, including agricultural and livestock. SEQUENOM was founded by Hubert Koester and Charles R. Cantor in 1994 and is headquartered in San Diego, CA.

Contact Information

3595 John Hopkins Court
San Diego California 92121-1331
P:(858) 202-9000
Investor Relations:
(858) 202-9028



Other institutional33.82%
Mutual fund holders22.37%
Individual stakeholders17.74%

Top Executives

William J. WelchPresident, Chief Executive Officer & Director
Carolyn D. BeaverChief Financial Officer & Senior Vice President
Dirk van den BoomDirector, Chief Scientific & Strategy Officer
Dave HendersonChief Information Officer
Daniel S. GrosuChief Medical Officer & Senior Vice President